Daly Jason B.
Insider CIK 1906486 · AMRX SVP, Chief Legal Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AMRX Amneal Pharmaceuticals, In | S Sale | 2026-08-12 | 2026-08-13 | 210,000 | $17.40 | $3.65M | 35,171 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | S Sale | 2026-08-12 | 2026-08-13 | 210,000 | $17.40 | $3.65M | 35,171 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | S Sale | 2026-08-11 | 2026-08-13 | 6,613 | $17.70 | $117.1K | 245,171 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | S Sale | 2026-08-11 | 2026-08-13 | 6,613 | $17.70 | $117.1K | 245,171 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2026-03-04 | 2026-03-05 | 35,880 | — | $0 | 71,760 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2026-03-04 | 2026-03-05 | 35,880 | — | $0 | 267,364 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2026-03-04 | 2026-03-05 | 15,580 | $13.30 | $207.2K | 251,784 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2026-03-03 | 2026-03-05 | 22,645 | — | $0 | 0 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2026-03-03 | 2026-03-05 | 38,226 | — | $0 | 38,227 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2026-03-03 | 2026-03-05 | 24,258 | — | $0 | 72,774 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2026-03-03 | 2026-03-05 | 305,810 | — | $0 | 0 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2026-03-03 | 2026-03-05 | 10,533 | $13.31 | $140.2K | 58,457 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2026-03-03 | 2026-03-05 | 10,147 | $13.31 | $135.1K | 23,104 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2026-03-03 | 2026-03-05 | 38,226 | — | $0 | 61,330 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2026-03-03 | 2026-03-05 | 16,598 | $13.31 | $220.9K | 44,732 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2026-03-03 | 2026-03-05 | 24,258 | — | $0 | 68,990 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2026-03-03 | 2026-03-05 | 22,645 | — | $0 | 33,251 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2026-03-03 | 2026-03-05 | 305,810 | — | $0 | 364,267 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2026-03-03 | 2026-03-05 | 132,783 | $13.31 | $1.77M | 231,484 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2026-03-02 | 2026-03-03 | 65,359 | — | $0 | 65,359 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2026-03-02 | 2026-03-03 | 65,359 | — | $0 | 65,359 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | S Sale | 2025-08-12 | 2025-08-13 | 22,000 | $9.05 | $199.1K | 10,606 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | S Sale | 2025-03-06 | 2025-03-07 | 46,936 | $8.73 | $409.8K | 32,606 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | S Sale | 2025-03-05 | 2025-03-07 | 43,064 | $8.88 | $382.4K | 79,542 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2025-03-04 | 2025-03-05 | 35,879 | — | $0 | 107,640 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2025-03-04 | 2025-03-05 | 35,879 | — | $0 | 138,185 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2025-03-04 | 2025-03-05 | 15,579 | $8.84 | $137.7K | 122,606 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2025-03-03 | 2025-03-05 | 194,064 | — | $0 | 194,064 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2025-03-03 | 2025-03-05 | 90,580 | — | $0 | 0 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2025-03-03 | 2025-03-05 | 38,226 | — | $0 | 76,453 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2025-03-03 | 2025-03-05 | 22,645 | — | $0 | 22,645 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2025-03-03 | 2025-03-05 | 97,032 | — | $0 | 97,032 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2025-03-03 | 2025-03-05 | 31,338 | $8.76 | $274.5K | 102,306 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2025-03-03 | 2025-03-05 | 90,580 | — | $0 | 133,644 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2025-03-03 | 2025-03-05 | 38,226 | — | $0 | 53,928 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2025-03-03 | 2025-03-05 | 6,943 | $8.76 | $60.8K | 15,702 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2025-03-03 | 2025-03-05 | 22,645 | — | $0 | 22,645 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2025-03-03 | 2025-03-05 | 10,864 | $8.76 | $95.2K | 43,064 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | S Sale | 2024-11-21 | 2024-11-22 | 13,665 | $8.40 | $114.8K | 0 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | S Sale | 2024-11-15 | 2024-11-19 | 43,657 | $8.61 | $375.9K | 13,665 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2024-03-04 | 2024-03-05 | 143,519 | — | $0 | 143,519 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2024-03-04 | 2024-03-05 | 287,038 | — | $0 | 287,038 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2024-03-03 | 2024-03-05 | 22,645 | — | $0 | 45,290 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2024-03-03 | 2024-03-05 | 38,226 | — | $0 | 114,679 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2024-03-03 | 2024-03-05 | 10,864 | $5.47 | $59.4K | 57,322 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2024-03-03 | 2024-03-05 | 38,226 | — | $0 | 68,186 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2024-03-03 | 2024-03-05 | 7,166 | $5.47 | $39.2K | 29,960 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2024-03-03 | 2024-03-05 | 22,645 | — | $0 | 37,126 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2023-03-03 | 2023-03-07 | 305,810 | — | $0 | 305,810 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2023-03-03 | 2023-03-07 | 152,905 | — | $0 | 152,905 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2023-03-03 | 2023-03-07 | 22,645 | — | $0 | 67,935 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2023-03-03 | 2023-03-07 | 22,645 | — | $0 | 22,645 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | F Tax w/h | 2023-03-03 | 2023-03-07 | 8,164 | $1.92 | $15.7K | 14,481 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2022-03-03 | 2022-03-03 | 90,580 | — | $0 | 90,580 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2022-03-03 | 2022-03-03 | 181,160 | — | $0 | 181,160 | SEC↗ |